UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

______________


FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



Date of report (Date of earliest event reported): March 4, 2014


BIODEL INC.
(Exact name of registrant as specified in its charter)



Commission File Number 001-33451


 

 

 

Delaware
(State or other jurisdiction of incorporation or organization)

 

90-0136863
(IRS Employer Identification Number)

 

 

 

100 Saw Mill Road

Danbury, Connecticut

(Address of principal executive offices)

 


06810

(Zip code)



(203) 796-5000

(Registrant's telephone number, including area code)



Not Applicable


(Former Name or Former Address, if Changed Since Last Report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


[  ]

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





Item 5.07

Submission of Matters to a Vote of Security Holders


On March 4, 2014, Biodel Inc. (the "Company") held its 2014 annual meeting of stockholders at the Company’s headquarters in Danbury, Connecticut (the “Annual Meeting”).  At the Annual Meeting, Errol B. De Souza and Barry Ginsberg were elected as Class I Directors, each for three-year terms, until the 2017 annual meeting of stockholders or until their respective successors are elected and qualified. At the Annual Meeting, the stockholders also (i) voted to approve, on an advisory basis, the compensation paid to the Company’s named executive officers as disclosed in the Company’s Proxy Statement for the Annual Meeting; and (ii) voted to ratify the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2014. The tabulation of the voting results is as follows:


Proposal Number One:  Election of Directors


Nominees

For

Withheld

Broker Non-Votes

Errol B. De Souza

4,950,707

82,052

11,096,698

Barry Ginsberg

4,960,857

71,902

11,096,698


Proposal Number Two:  Approval of Compensation Paid to Named Executive Officers


For

Against

Abstain

Broker Non-Votes

4,765,845

164,432

102,482

11,096,698


Proposal Number Three:  Ratification of Appointment of Independent Registered Public Accounting Firm


For

Against

Abstain

14,965,340

424,925

739,192

          





2




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date:

March 10, 2014

BIODEL INC.


By:  /s/ Paul S. Bavier                                         

       Paul S. Bavier, General Counsel




3